The Indonesia Investment Authority (INA) and the Silk Road Fund group are new investors in Kimia Farmas (KAEF) pharmacy network subsidiary, PT Kimia Farma Apotek (KFA). KAEF completed the sale of a portion of KFA shares and issued new KFA shares which were bought by INA and the Silk Road Fund. The investments provide additional capital of IDR 1.86 trillion, equivalent to a 40 per cent stake.